Table 2.
Expression profile of SNX9 protein in human colorectal cancer tissues. Total 57 of human colorectal cancer tissues were subjected to immunohistochemistry for SNX9. The number of human colorectal cancer tissues with SNX9‐positive tumor endothelial or epithelial cells were counted. See also Materials and Methods
| Number and percentage of human colorectal cancer tissues | ||
|---|---|---|
| With SNX9‐positive tumor endothelial cells | With SNX9‐positive epithelial cells | |
| Stage | ||
| I | 1/3 (33%) | 2/3 (67%) |
| II | 17/20 (85%) | 17/20 (85%) |
| III | 22/29 (76%) | 25/29 (86%) |
| IV | 4/4 (100%) | 4/4 (100 %) |
| Histological grade | ||
| Well differentiated | 19/22 (86 %) | 19/22 (86 %) |
| Moderately differentiated | 23/30 (77 %) | 25/30 (83 %) |
| Poorly differentiated (solid type) | 2/3 (67 %) | 3/3 (100 %) |
| Poorly differentiated (non‐solid type) | 1/1 (100 %) | 1/1 (100 %) |
| Mucinous | 0/1 (0 %) | 1/1 (100 %) |
| Location of tumor | ||
| Appendix vermiformis | 0/1 (0 %) | 1/1 (100 %) |
| Cecum | 2/3 (67 %) | 3/3 (100 %) |
| Ascending colon | 11/13 (85 %) | 12/13 (92 %) |
| Transverse colon | 5/5 (100 %) | 5/5 (100 %) |
| Descending colon | 3/5 (60 %) | 4/5 (80 %) |
| Sigmoid colon | 9/11 (82 %) | 9/11 (82 %) |
| Rectum | 15/19 (79 %) | 15/19 (79 %) |
| Lymphovascular invasion | ||
| Present | 45/56 (80 %) | 49/56 (88 %) |
| Absent | 0/1 (0 %) | 0/1 (0 %) |
| Level of invasion | ||
| T1 | 0/1 (0 %) | 0/1 (0 %) |
| T2 | 2/3 (67 %) | 3/3 (100 %) |
| T3 | 27/34 (79 %) | 29/34 (85 %) |
| T4 | 16/19 (84 %) | 17/19 (89 %) |
Note. SNX9: sorting nexin 9.